The goal of this study was to develop a new model of ischemia-induced seizures in immature rats using injection of vasoconstrictor Endothelin-1 (ET-1) into the brain. ET-1 (10, 20, or 40 pmol) was infused into the left dorsal hippocampus of freely moving Wistar rats 12 (P12) and 25 (P25) days old. Animals were then video/EEG-monitored for 100 min and monitoring was repeated 22 h later. Parameters of electrographic seizures (frequency and mean duration) as well as pattern of their behavioral correlates were evaluated. The pattern of behavioral seizures was used to develop model-specific scoring system. Cresyl violet and Fluoro Jade-B-staining were used to evaluate brain damage. Extension of the lesion was correlated with seizure severity. After ET-1-injection, seizures occurred in 83-100% animals of all age-and-dose groups and persisted for 24 h except P12 rats with 10 pmol. There were no differences in average seizure duration (18-40 s) or seizure frequency (3-7 seizures/100 min) among individual dose-groups. Between the 1st and 2nd observation period, total seizure duration decreased in 71% of P12 and 47% of P25 rats. Electrographic seizure activity was most frequently accompanied by clonus, incidence of more severe convulsions (barrel rolling or generalized clonic seizures) increased with dose of ET-1. Morphologic examination did not reveal any dose-related difference in damage severity, hippocampal damage was however more extensive in P12 compared to P25 animals. Seizure severity correlated positively with severity of the damage in both age groups. Our study presents focal injection of ET-1 into the brain as a new and practical model of ischemia-induced seizures in immature rats.

Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic

Erratum in: Epilepsia. 2007 Dec;48(12):2379.

000      

00000naa 2200000 a 4500

001      

bmc10012912

003      

CZ-PrNML

005      

20111210163342.0

008      

100528s2007 xxu e eng||

009      

AR

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Tsenov, Grigorij, $d 1980- $7 xx0103054

245    10

$a Intrahippocampal injection of endothelin-1: a new model of ischemia-induced seizures in immature rats / $c Tsenov G, Mátéffyová A, Mares P, Otáhal J, Kubová H.

314    __

$a Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

500    __

$a Erratum in: Epilepsia. 2007 Dec;48(12):2379.

520    9_

$a The goal of this study was to develop a new model of ischemia-induced seizures in immature rats using injection of vasoconstrictor Endothelin-1 (ET-1) into the brain. ET-1 (10, 20, or 40 pmol) was infused into the left dorsal hippocampus of freely moving Wistar rats 12 (P12) and 25 (P25) days old. Animals were then video/EEG-monitored for 100 min and monitoring was repeated 22 h later. Parameters of electrographic seizures (frequency and mean duration) as well as pattern of their behavioral correlates were evaluated. The pattern of behavioral seizures was used to develop model-specific scoring system. Cresyl violet and Fluoro Jade-B-staining were used to evaluate brain damage. Extension of the lesion was correlated with seizure severity. After ET-1-injection, seizures occurred in 83-100% animals of all age-and-dose groups and persisted for 24 h except P12 rats with 10 pmol. There were no differences in average seizure duration (18-40 s) or seizure frequency (3-7 seizures/100 min) among individual dose-groups. Between the 1st and 2nd observation period, total seizure duration decreased in 71% of P12 and 47% of P25 rats. Electrographic seizure activity was most frequently accompanied by clonus, incidence of more severe convulsions (barrel rolling or generalized clonic seizures) increased with dose of ET-1. Morphologic examination did not reveal any dose-related difference in damage severity, hippocampal damage was however more extensive in P12 compared to P25 animals. Seizure severity correlated positively with severity of the damage in both age groups. Our study presents focal injection of ET-1 into the brain as a new and practical model of ischemia-induced seizures in immature rats.

650    _2

$a novorozená zvířata $7 D000831

650    _2

$a zvířata $7 D000818

650    _2

$a ischemie mozku $x chemicky indukované $x patofyziologie $x patologie $7 D002545

650    _2

$a elektroencefalografie $x statistika a číselné údaje $7 D004569

650    _2

$a endotelin-1 $x aplikace a dávkování $x farmakologie $7 D019332

650    _2

$a epilepsie $x chemicky indukované $x patofyziologie $x patologie $7 D004827

650    _2

$a hipokampus $x patofyziologie $x patologie $x účinky léků $7 D006624

650    _2

$a injekce $7 D007267

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a potkani Wistar $7 D017208

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a videozáznam $7 D014743

650    _2

$a financování organizované $7 D005381

700    1_

$a Matéffyová, Adéla. $7 _AN040719

700    1_

$a Mareš, Pavel, $d 1937- $7 jo20000074131

700    1_

$a Otáhal, Jakub $7 xx0105144

700    1_

$a Kubová, Hana, $d 1959- $7 xx0036699

773    0_

$w MED00001567 $t Epilepsia $g Roč. 48, Suppl 5 (2007), s. 7-13 $x 0013-9580

910    __

$a ABA008 $b x $y 8

990    __

$a 20100528143347 $b ABA008

991    __

$a 20100827102503 $b ABA008

999    __

$a ok $b bmc $g 726767 $s 589943

BAS    __

$a 3

BMC    __

$a 2007 $b 48 $c Suppl 5 $d 7-13 $m Epilepsia $x MED00001567

LZP    __

$a 2010-B2/dkme